-Frontline There are no effective vaccines against Japanese encephalitis, but its spread can be controlled in India through vector management.  JAPANESE ENCEPHALITIS, or JE, has become endemic in many parts of the country, occurring repeatedly in epidemic form in many of them—for instance, in parts of Gorakhpur in northern Uttar Pradesh. One can expect JE-type epidemics year after year in States where prolonged drought-like conditions are followed by heavy monsoons. This leads to...

-The Hindustan Times With the detection of fresh cases of dengue fever every day, the state capital seems to be falling in the grip of the infection. Altogether, 132 cases have been reported from different parts of Patna till date.   “Though the disease has not yet taken the shape of an epidemic, the situation may take an ugly turn if health authorities fail to initiate steps on a war footing to...

-The Hindu ADGP promises impartial probe into caste violence P. L. Punia, Chairman, National Commission for Scheduled Castes (NCSC), on Monday will visit three Dalit colonies in Naikkankottai village of Dharmapuri district, which witnessed caste violence last week. He will be accompanied by Lata Priyakumar, member, NCSC, sources in the district administration said here on Sunday. On Saturday, D. Venkatesan, director, NCSC, State Office in Chennai, visited the colonies, while on Sunday, T.K. Rajendran,...

-The Hindu The government has approved a Rs. 4,038 crore programme to tackle the Japanese encephalitis and acute encephalitis syndrome in 60 priority districts With thousands of young lives being lost and an equal number of children rendered disabled for life, the government has prepared a comprehensive strategy to tackle Japanese encephalitis (JE) and acute encephalitis syndrome (AES). The dreaded disease has already spread to 17 States affecting 171 districts. With the Cabinet...

-The Hindu Drugs Controller must be told of adverse events within 24 hours Under sharp criticism for inadequate monitoring of clinical trials in the country, the Union Government is contemplating major changes in the Drugs & Cosmetics Act, 1940, and its Rules. These would make it mandatory for the Investigator to report all serious adverse events, including deaths, to the Drugs Controller General of India (DGCI), as well as the sponsor and...